Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adeline Dolly"'
Autor:
Adeline Dolly, Sarah A. Pötgens, Morgane M. Thibaut, Audrey M. Neyrinck, Gabriela S. deCastro, Chloé Galbert, Camille Lefevre, Elisabeth Wyart, Silvio P. Gomes, Daniela C. Gonçalves, Nicolas Lanthier, Pamela Baldin, Joshua R. Huot, Andrea Bonetto, Marília Seelaender, Nathalie M. Delzenne, Harry Sokol, Laure B. Bindels
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 3, Pp 1569-1582 (2023)
Abstract Background The aryl hydrocarbon receptor (AHR) is expressed in the intestine and liver, where it has pleiotropic functions and target genes. This study aims to explore the potential implication of AHR in cancer cachexia, an inflammatory and
Externí odkaz:
https://doaj.org/article/5bc931a787c441b1b90f54ab9bc830c5
Autor:
Adeline Dolly, Thierry Lecomte, Nicolas Tabchouri, Morgane Caulet, Nicolas Michot, Benjamin Anon, Romain Chautard, Yoann Desvignes, Mehdi Ouaissi, Gaëlle Fromont‐Hankard, Jean‐François Dumas, Stéphane Servais
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 3, Pp 1837-1849 (2022)
Abstract Background Cancer cachexia is a multifactorial syndrome characterized by involuntary and pathological weight loss, mainly due to skeletal muscle wasting, resulting in a decrease in patients' quality of life, response to cancer treatments, an
Externí odkaz:
https://doaj.org/article/6a68b874a41c439bb8a225535c7618c3
Autor:
Helene Salaun, Mathilde Poisson, Adeline Dolly, Flavie Arbion, Stéphane Servais, Jean François Dumas, Caroline Goupille, Lobna Ouldamer
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1768 (2023)
Prognostic factors for epithelial ovarian cancers (EOCs) are in particular clinical factors such as pathology staging at diagnosis (FIGO stages), genetic mutation, or histological phenotypes. In the present study, FIGO stage, tumor residue after surg
Externí odkaz:
https://doaj.org/article/78631d9717694eaa9163b9c1674ba618
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Research investigators have shown a growing interest in investigating alterations underlying skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions associated with cancer cachexia have mainly been studied in preclinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d321578a6a3cd2067976ddf88d9b92d1
https://pubmed.ncbi.nlm.nih.gov/33053604
https://pubmed.ncbi.nlm.nih.gov/33053604
Autor:
Morgane M. Thibaut, Justine Gillard, Adeline Dolly, Martin Roumain, Isabelle A. Leclercq, Nathalie M. Delzenne, Giulio G. Muccioli, Laure B. Bindels
Publikováno v:
Cancers, Vol 13, Iss 6389, p 6389 (2021)
Cancers
Cancers; Volume 13; Issue 24; Pages: 6389
Cancers, Vol. 13, no.24, p. 6389 [1-17] (2021)
Cancers
Cancers; Volume 13; Issue 24; Pages: 6389
Cancers, Vol. 13, no.24, p. 6389 [1-17] (2021)
SIMPLE SUMMARY : Cancer cachexia is considered a multi-organ syndrome. An improved understanding of how circulating molecules can affect tissues and mediate their crosstalk in the pathogenesis of cancer cachexia is emerging. Considering the various a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da80fcb5ee7d285046e1c6f22fd7a8d3
https://doi.org/10.3390/cancers13246389
https://doi.org/10.3390/cancers13246389